Duodenal levodopa infusion for the treatment of Parkinson's disease.
about
Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?Transdermal rotigotine: a clinically innovative dopamine-receptor agonist for the management of Parkinson's diseaseTreatment of advanced Parkinson's diseaseTreatment options for non-motor symptoms in late-stage Parkinson's disease.Apomorphine and levodopa infusion therapies for advanced Parkinson's disease: selection criteria and patient management.What is the best treatment for fluctuating Parkinson's disease: continuous drug delivery or deep brain stimulation of the subthalamic nucleus?High frequency deep brain stimulation of the subthalamic nucleus versus continuous subcutaneous apomorphine infusion therapy: a review.New non-oral drug delivery systems for Parkinson's disease treatment.Future treatments for Parkinson's disease: surfing the PD pipeline.IPX066: a novel carbidopa-levodopa extended-release formulation.Continuous intestinal infusion of levodopa/carbidopa in advanced Parkinson's disease: efficacy, safety and patient selection.Treatment of motor fluctuations in Parkinson's disease: recent developments and future directions.Safinamide for the treatment of Parkinson's disease.Apomorphine and levodopa infusion therapies for advanced Parkinson's disease.Carbidopa levodopa enteral suspension.Novel Approaches to Optimization of Levodopa Therapy for Parkinson's Disease.Visualization and quantification of intestinal transit and motor function by real-time tracking of 19F labeled capsules in humans.Therapy for dyskinesias in Parkinson’s disease patients
P2860
Q27021464-C63515CC-6C5E-4080-A00B-248A74CB3186Q28266116-B2400B2C-CB5B-4CA5-827D-37A97D9BF6B5Q30476968-B932BF07-8CC2-4819-B5D0-1F79C28917D3Q37098986-27054631-5954-4230-9FEC-23B4725EB04CQ37507973-C57C5218-0C86-4C44-9205-D1F17CF95609Q37824279-17D16A67-4537-4414-8D8C-62B16B254295Q37824441-8ED5DBD9-4E5A-44CF-A6EF-396DADA0EF07Q37840165-F30B24F6-C25A-4EF1-ABB5-A36356EBCCB0Q37950428-073D7601-16F6-4525-B8CC-1641EEE12991Q37979870-0A757940-BA10-46DC-9A61-F40010501FEEQ38080952-4419DD2D-3A80-4078-ADEE-572A0FFED820Q38170421-98BCE1CB-950B-45BD-9D45-BBA570FF16FFQ38197710-CC543811-B29F-4A4A-A0E9-984B2EEDF115Q38215506-ABB4E442-5DB2-43D7-A271-BFCF542C6765Q38643494-E3298368-4C3F-4153-BF06-AB54A21710C4Q38742792-9B656C3C-023A-4690-BBB8-D915D65D968CQ50686179-B6F87239-1047-4860-9D4C-1194D608738BQ57518128-7711C4F3-FF51-4C3F-B8FD-500BDBAB873E
P2860
Duodenal levodopa infusion for the treatment of Parkinson's disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Duodenal levodopa infusion for the treatment of Parkinson's disease.
@ast
Duodenal levodopa infusion for the treatment of Parkinson's disease.
@en
type
label
Duodenal levodopa infusion for the treatment of Parkinson's disease.
@ast
Duodenal levodopa infusion for the treatment of Parkinson's disease.
@en
prefLabel
Duodenal levodopa infusion for the treatment of Parkinson's disease.
@ast
Duodenal levodopa infusion for the treatment of Parkinson's disease.
@en
P2860
P356
P1476
Duodenal levodopa infusion for the treatment of Parkinson's disease.
@en
P2093
Johan Samanta
P2860
P304
P356
10.1517/14656566.8.5.657
P407
P577
2007-04-01T00:00:00Z